Pradeep K. Das
Bhubaneshwar, OR, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 283 publications
Open-label Randomized Controlled Trial of Controlled-release Formulation Budesonide in Indian Proteinuric IgA Nephropathy Patients.
Journal: Kidney medicine
Published: March 02, 2026
Design and Synthesis of New Pyrazolo[1,5-c]quinazolin-5-amines as Potential TLR7/8 Modulators.
Journal: ChemMedChem
Published: November 19, 2025
WGS analysis and functional studies illustrate promising gene-signatures for probiotic attributes and molecular-targeted therapeutic prospects of Lactiplantibacillus plantarum LP-ARP2.
Journal: Archives of microbiology
Published: November 08, 2025
ApoA1-driven cholesterol efflux and macrophage polarization orchestrate T-cell differentiation towards controlling Leishmania donovani pathogenesis.
Journal: Scientific reports
Published: September 25, 2025
Cyclodextrin-AmB-IL-10 antagonist peptide nanoparticles treat leishmaniasis more effectively than conventional AmB.
Journal: Nanomedicine (London, England)
Published: August 29, 2025
Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis.
Journal: International journal of antimicrobial agents
Published: August 05, 2025
Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing.
Journal: Clinical pharmacology and therapeutics
Published: July 30, 2025
Structural insights into Leishmania donovani mevalonate kinase and its interaction with toll-like receptors during early infection.
Journal: Acta tropica
Published: June 16, 2025
The potential of Leishmania donovani Aurora kinase in the diagnosis of Indian and Brazilian visceral leishmaniasis patients.
Journal: Microbiology spectrum
Published: April 16, 2025
Antigens activated SOCS3+CD200R+CD4+ T cells are critical to Leishmania pathogenesis and a distinctive target for vaccine development.
Journal: Vaccine
Published: March 09, 2025
Recombinant Leishmania-activated C kinase as a novel antigenic candidate for immuno-diagnosis of visceral leishmaniasis occurring in India and Brazil.
Journal: Infectious diseases of poverty
Published: November 29, 2024
Last Updated: 09/26/2026